Replies to post #5274 on Geron Corp (GERN)

[healthywelth]

This is just the complete Right way to look at it.....
Janssen is not about to divorce Geron. Rather, when asked during Johnson & Johnson's Q1 2018 earnings CC by Geoff Meacham as to its strategy around its pipeline and acquisitions, Johnson & Johnson's EVP and CFO Caruso assured Meacham that its pipeline was strong. In this regard he specifically referenced eight new drug applications for products having billion-dollar potential planned by 2021.

Caruso's response ties in directly with Johnson & Johnson's Q1 2018 pipeline slide - The First one listed is IMETELSTAL for Myelofibrosis.




Caruso's response references eight drugs set for filing. Johnson & Johnson's 4/18/18 slide references eight planned NME filings by 2021. The first one listed is imetelstat for Myelofibrosis. I take this as meaning that Johnson & Johnson has specific intent of following through on expectations around issuing its continuation decision.


p.s. Nice try Dump , your short position is $5.00 ..... Target Geron to hit $10 by 10/10........